2022Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 - a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein-like Receptor 1- on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction.
Journal of cardiovascular pharmacology.80(5):672-678[DOI] 10.1097/FJC.0000000000001331.[PMID] 35881895.